The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Net Asset Value(s)

3 Jan 2019 12:05

RNS Number : 1402M
HSBC ETFs FTSE EPRA/NAREIT Dev $
03 January 2019
 

[03.01.19]

HSBC ETFs plc

Net Asset Val

Fund: HSBC FTSE EPRANAREIT DEVELOPED UCITS ETF

Valuation Date

ISIN Code

Shares in Issue

Currency

Share Redeemed since Previous Valuation

NET Asset Value

NAV per Share

Ex Dividend Date

02/01/2019

IE00B5L01S80

6,800,000

USD

0

$145,360,886.90

$21.3766

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NAVGMGGMZFDGLZM

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.